Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
The Journal of pharmacy and pharmacology • 1978 | View Paper
“In addition, morphine treatment induced the expression of suppressor of cytokine signaling protein-1, 2, 3 (SOCS-1, 2, 3) and protein inhibitors of activated STAT-1, 3, X, Y (PIAS-1, 3, X, Y), the key negative regulators of IFN signaling pathway.”
European journal of pharmacology • 1999 | View Paper
“Furthermore, we show by site-directed mutagenesis that tyrosine (Y382–384) within the P2X7R C-terminus is differentially modulated by repeated morphine treatment and has no bearing on normal P2X7R function.”
Naunyn-Schmiedeberg's Archives of Pharmacology • 2004 | View Paper
“ Morphine also resulted in IRS-1 phosphorylation at serine 612 and reduced tyrosine phosphorylation at the YMXM p85-binding motifs, weakening the association of the IRS-1/p85 phosphatidylinositol 3-kinase complex.”
Molecular and Cellular Biology • 2003 | View Paper
“Acute administration of morphine (5, 10 and 20 mg/kg) produced dose-dependent increases in blood glucose concentration which were insignificantly potentiated by L-tyrosine (25-200 mg/kg) when given together with morphine.”
The Journal of pharmacology and experimental therapeutics • 1994 | View Paper
“ Morphine , at a concentration of 1 x 10(-5)M increases the incorporation of tritiated tyrosine into dopamine and dihydroxy phenylacetic acid in synaptosomal preparations.”
Biochemistry and molecular biology international • 1994 | View Paper
“ Acute morphine sulfate (50 mg/kg) increased dihydroxyphenylacetic acid/dopamine ratios (DOPAC/DA) (+20%), the conversion of [3H]tyrosine to [3H]dopamine (+73%) and open-field activity (+130%) in CD-1 male mice.”